9
Participants
Start Date
January 20, 2022
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2024
CC-96673
IV Infusion
Local Institution - 401, Madrid
Local Institution - 403, Málaga
Local Institution - 302, Montpellier
Local Institution - 402, Salamanca
Local Institution - UNK-5, Angers
Local Institution - 104, Minneapolis
Local Institution - 303, Lille
Hopital Lyon Sud, Pierre-Bénite
Local Institution - 101, Houston
Local Institution - 102, Seattle
Local Institution - 103, Omaha
Local Institution - 201, Toronto
Local Institution - 202, Montreal
Lead Sponsor
Celgene
INDUSTRY